These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29749454)

  • 1. USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway.
    Tan Y; Zhou G; Wang X; Chen W; Gao H
    Int J Oncol; 2018 Jul; 53(1):371-383. PubMed ID: 29749454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression and prognosis of Emi1 and Skp2 in breast carcinoma: associated with PI3K/Akt pathway and cell proliferation.
    Liu X; Wang H; Ma J; Xu J; Sheng C; Yang S; Sun L; Ni Q
    Med Oncol; 2013 Dec; 30(4):735. PubMed ID: 24277465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via microRNA-7.
    Duex JE; Comeau L; Sorkin A; Purow B; Kefas B
    J Biol Chem; 2011 Jul; 286(28):25377-86. PubMed ID: 21592959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway.
    Diao W; Guo Q; Zhu C; Song Y; Feng H; Cao Y; Du M; Chen H
    BMC Cancer; 2020 Aug; 20(1):741. PubMed ID: 32770981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma.
    Liang C; Ma Y; Yong L; Yang C; Wang P; Liu X; Zhu B; Zhou H; Liu X; Liu Z
    Cancer Sci; 2019 Jan; 110(1):166-179. PubMed ID: 30426615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
    Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
    Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP18 and ISG15 coordinately impact on SKP2 and cell cycle progression.
    Vuillier F; Li Z; Commere PH; Dynesen LT; Pellegrini S
    Sci Rep; 2019 Mar; 9(1):4066. PubMed ID: 30858391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting the role of Skp2 suppresses cell proliferation and tumorigenesis of human gastric cancer cells via the upregulation of p27kip1.
    Wen Y; Wang K; Yang K
    Mol Med Rep; 2016 Oct; 14(4):3917-24. PubMed ID: 27572672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.
    Zuo T; Liu R; Zhang H; Chang X; Liu Y; Wang L; Zheng P; Liu Y
    J Clin Invest; 2007 Dec; 117(12):3765-73. PubMed ID: 18008005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway.
    Liu SG; Wang BS; Jiang YY; Zhang TT; Shi ZZ; Yang Y; Yang YL; Wang XC; Lin DC; Zhang Y; Yang H; Cai Y; Zhan QM; Wang MR
    Mol Cancer Res; 2011 Apr; 9(4):390-402. PubMed ID: 21310827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP18 contributes to the proliferation and migration of ovarian cancer cells by regulating the AKT/mTOR signaling pathway.
    Liu M; Gao S; Xu X; Zhang L; Xu B; Lu D
    Acta Biochim Pol; 2022 Jun; 69(2):417-422. PubMed ID: 35696596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation.
    Zhang W; Cao L; Sun Z; Xu J; Tang L; Chen W; Luo J; Yang F; Wang Y; Guan X
    Cell Cycle; 2016 May; 15(10):1344-51. PubMed ID: 27111245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer.
    Shao B; Feng Y; Zhang H; Yu F; Li Q; Tan C; Xu H; Ying J; Li L; Yang D; Peng W; Tang J; Li S; Ren G; Tao Q; Xiang T
    J Cell Mol Med; 2018 Feb; 22(2):1257-1271. PubMed ID: 29193730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
    Li F; Dong X; Lin P; Jiang J
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skp2-dependent reactivation of AKT drives resistance to PI3K inhibitors.
    Clement E; Inuzuka H; Nihira NT; Wei W; Toker A
    Sci Signal; 2018 Mar; 11(521):. PubMed ID: 29535262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIN1 promotes the proliferation and migration of breast cancer cells by Akt activation.
    Wang D; Wu P; Wang H; Zhu L; Zhao W; Lu Y
    Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 27780891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway.
    Zhang X; Gao D; Fang K; Guo Z; Li L
    Cancer Lett; 2019 Mar; 444():105-115. PubMed ID: 30583076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis.
    Chen J; Wang W; Wang H; Liu X; Guo X
    Drug Discov Ther; 2014 Feb; 8(1):33-41. PubMed ID: 24647156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.
    Wang G; Wang J; Chang A; Cheng D; Huang S; Wu D; Sirkisoon S; Yang S; Lin HK; Lo HW; Xiang R; Sun P
    Oncogene; 2020 Nov; 39(47):7034-7050. PubMed ID: 32989258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.